Ind-Swift Laboratories Limited

Overview

Ind-Swift Laboratories Limited is a leading pharmaceutical company specializing in the manufacturing of active pharmaceutical ingredients (APIs). It is known for its strong presence in the generic drug market.

Therapeutic areas

API / Drug Master Files

Ind-Swift Laboratories Limited holds 0 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DUTASTERIDE USPInactive2014-06-13
• COLESEVELAM HYDROCHLORIDEInactive2013-02-05
• CLOPIDOGREL CAMPHOR SULFONATEInactive2012-04-20
• CLOPIDOGREL BISULFATE USPInactive2011-02-15
• TELMISARTANInactive2011-01-05
• CLARITHROMYCIN CITRATEInactive2009-03-09
• NARATRIPTAN HYDROCHLORIDE USPInactive2008-12-26
• CLARITHROMYCIN SPECIALInactive2006-02-18
• ARIPIPRAZOLEInactive2006-02-14
• AT1 DRUG SUBSTANCE INTERMEDIATEInactive2005-09-17
• QUETIAPINE FUMARATEInactive2005-09-12
• VENLAFAXINE HYDROCHLORIDEInactive2005-03-01

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Ind-Swift Laboratories Limited in our records. PharmaTek screens the full directory against live FDA enforcement data.